detogesic 10 mg/ml inj. sol. i.v. vial
vetcare oy - detomidine hydrochloride 10 mg/ml - eq. detomidine 8,36 mg/ml - solution for injection - 10 mg/ml - detomidine hydrochloride 10 mg/ml - detomidine - horse
detogesic 10 mg/ml inj. sol. i.v. vial
vetcare oy - detomidine hydrochloride 10 mg/ml - eq. detomidine 8,36 mg/ml - solution for injection - 10 mg/ml - detomidine hydrochloride 10 mg/ml - detomidine - horse
detonervin 10 mg/ml inj. sol. i.v./i.m. vial
le vet pharma b.v. - detomidine hydrochloride 10 mg/ml - solution for injection - 10 mg/ml - detomidine hydrochloride 10 mg/ml - detomidine - cattle; horse
domidine 10 mg/ml inj. sol. i.m./i.v.
dechra regulatory b.v. - detomidine hydrochloride 10 mg/ml - solution for injection - 10 mg/ml - detomidine hydrochloride 10 mg/ml - detomidine - cattle; horse
domosedan 10 mg/ml inj. susp. i.m./i.v. vial
orion corp. - detomidine hydrochloride 10 mg/ml - suspension for injection - 10 mg/ml - detomidine hydrochloride 10 mg/ml - detomidine - cattle; horse
medesedan 10 mg/ml inj. sol. i.m./i.v. vial
cp-pharma handelsgesellschaft gmbh - detomidine hydrochloride 10 mg/ml - solution for injection - 10 mg/ml - detomidine hydrochloride 10 mg/ml - detomidine - cattle; horse
equisedan vet 10mg/ml solution for injection
ausrichter pty ltd - detomidine hydrochloride - parenteral liquid/solution/suspension - detomidine hydrochloride imidazole active 10.0 mg/ml - anaesthetics/analgesics - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - analgesic | sedative | antipyretic | colic | muscle relaxant | sedative | spasmolytic
dexmedetomidine hydrochloride- dexmedetomidine hydrochloride injection, solution
actavis pharma, inc. - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine 100 ug in 1 ml - dexmedetomidine hydrochloride injection is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. none teratogenic effects: pregnancy category c there are no adequate and well-controlled studies of dexmedetomidine hydrochloride injection use in pregnant women. in an in vitro human placenta study, placental transfer of dexmedetomidine occurred. in a study in the pregnant rat, placental transfer of dexmedetomidine was observed when radiolabeled dexmedetomidine was administered subcutaneously. thus, fetal exposure should be expected in humans, and dexmedetomidine hydrochloride injection should be used during pregnancy only if the potential benefits justify the potential risk to the fetus. teratogenic effects were not observed in rats following subcutaneous administration of dexmedetomidine during the period of fetal organogenesis (from gestation day 5 to 16) with doses up to 200 mcg/kg (representing a dose approximately equal to the maximum recommended human intra
somnipron 10 mg/ml solution for injection for horses and cattle
vetpharma animal health, s.l. - detomidine hydrochloride (equivalent to detomidine) - solution for injection - 10 mg/ml - detomidine - bovine, equine - food - sedative
dexmedetomidine injection, solution dexmedetomidine hydrochloride- dexmedetomidine hydrochloride in 0.9% sodium chloride inject
eugia us llc - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine 100 ug in 1 ml - dexmedetomidine injection is indicated for sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. dexmedetomidine injection should be administered by continuous infusion not to exceed 24 hours. dexmedetomidine injection has been continuously infused in mechanically ventilated adult patients prior to extubation, during extubation, and post-extubation. it is not necessary to discontinue dexmedetomidine injection prior to extubation. dexmedetomidine injection is indicated for sedation of non-intubated adult patients prior to and/or during surgical and other procedures. pediatric use information is approved for hospira inc.’s precedextm (dexmedetomidine hydrochloride) injection and precedextm (dexmedetomidine hydrochloride) in sodium chloride injection. however, due to hospira inc.’s marketing exclusivity rights, this drug product is not labeled with that information. none. risk summary available data from published randomized controll